In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1858 News Items found
Memorial Sloan Kettering ovarian cancer patient Vilma Rosario and her partner, Michele Freeman, pose at the Statue of Liberty.
Feature
Ovarian Cancer Didn’t Cuff This Cop

Meet a former NYPD officer who is battling a vicious enemy - ovarian cancer - with support from her new wife.
Palliative care nurse practitioner Tammy Son
In the Clinic
At MSK, Nurse Researchers Are Studying Ways to Improve Cancer Care

Learn how nurses at MSK also engage in cancer research projects designed to help improve patients’ treatment, symptoms, or experience.
MSK Pediatric Prom
Feature
Celebrating School’s End at MSK with Pediatric Prom and High School Convocation

Discover how current and former Memorial Sloan Kettering pediatric cancer patients closed out the end of the school year.
MSK gynecologic oncologist Carol Brown
Q&A
Q & A with Carol Brown: Clinical Trials and Cancer Disparities

MSK physician Carol Brown spoke about cancer disparities at The US State of Women Summit organized by the White House. Learn how she and MSK are leading the way in addressing this issue.
MSK physician Aimee Crago consults with two colleagues.
In the Clinic
New Targeted Drug Therapy for Advanced Sarcoma Extends Survival by Nearly a Year

Learn more about olaratumab, a promising drug that has been shown to extend survival for people with advanced soft tissue sarcoma — particularly leiomyosarcoma — by nearly a year in a phase II clinical trial.
Memorial Sloan Kettering Study Shows Targeted Therapy for Advanced Sarcoma Extends Survival by Nearly a Year

A new drug is being shown to extend the lives of patients with advanced soft tissue sarcoma by almost a year. The results of a multicenter phase II trial evaluating the efficacy and safety of olaratumab in combination with doxorubicin chemotherapy was published in The Lancet on June 9. William Tap, MD, Chief of the Sarcoma Medical Oncology Service at Memorial Sloan Kettering Cancer Center (MSK), served as corresponding author on this study, which met its primary endpoint of progression-free survival and showed a statistically significant improvement in overall survival. To arrange an interview with Dr. Tap, please email [email protected].
Vice President Joe Biden.
In the News
#ASCO16 Highlights: Treating Cancer in the Older Patient, a Visit from VP Biden, and More

In case you missed it, here’s a recap of Monday’s highlights from the American Society of Clinical Oncology annual meeting.
Two cancer researchers at the American Society of Clinical Oncology annual meeting
In the News
#ASCO16 Highlights: A "Smart-Bomb" for Lung Cancer, Bladder Cancer Advances, and More

Couldn’t be at ASCO this year? Read highlights from the first half of the meeting.
A woman who is exercising checks her heart rate.
In the Lab
Women with Early Breast Cancer Can Ward Off Heart Problems with Exercise

Discover how exercise can reduce the long-term risk of cardiovascular disease in women with early-stage breast cancer.
Q&A
Combination Immunotherapy Shows New Promise for Lung Cancer

Results to be presented at the upcoming American Society of Clinical Oncology (ASCO) meeting suggest combination immunotherapy may help more people with the most common form of lung cancer.